Gender Differences in Predictors of Heart Failure Morbidity and Mortality in an Urban Swedish Population: The Malm Preventive ProjectHeart failuremortalitypredictorsmenwomenObjective/Background: Reports on heart failure (HF) predictors are scarce. We assessed gender-specific HF predictors. Design: ...
Guideline-directed medical therapy (GDMT) remains underutilized in patients with heart failure with reduced ejection fraction, leading to morbidity and mortality. 指南导向的药物治疗(GDMT)在射血分数降低的心力衰竭患者中仍未得到充分...
Heart Failure Morbidity, Mortality, and Its Relationship to Hypertension Book Title Hypertension in High Risk African Americans Book Subtitle Current Concepts, Evidence-based Therapeutics and Future Considerations Pages pp 111-122 Copyright 2015 DOI 10.1007/978-1-4939-2010-5_7 Print ISBN 978-1-4939...
Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-ter... Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-...
Lifestyle modifications decrease morbidity and mortality in heart failure . Weight loss Exercise (contraindicated if decompensating) Restriction of sodium to 3 g/day Restriction of fluids to 1.5–2 L/day in volume overload/ edema Weight monitoring (if > 5 lb weight gain, consult a physician...
Heart failure (HF) is a heterogenous and life-threatening syndrome that affects more than 60 million individuals globally and is characterised by severe morbidity and mortality, poor quality of life, and a high burden on the healthcare system...
Heart failure represents a major cause of morbidity and mortality worldwide. Single-cell transcriptomics have revolutionized our understanding of cell composition and associated gene expression. Through integrated analysis of single-cell and single-nucleus RNA-sequencing data generated from 27 healthy donors...
Heart failure (HF) is a leading cause of morbidity and mortality worldwide. A small proportion of HF cases are attributable to monogenic cardiomyopathies and existing genome-wide association studies (GWAS) have yielded only limited insights, leaving the
Heart failure (HF) is an increasingly important cause of morbidity and mortality. The annual incidence of HF in the U.S. has recently been estimated at 465,000 and is steadily rising, despite advances in medical therapy. Five-year survival rates are near 50% (1). Obesity is regarded as ...
and the ability to alter the natural history of the disease has never been better. Recent developments include SGLT2 inhibitors, vericiguat, and transcatheter mitral valve repair, all of which incrementally improve prognosis beyond foundational neurohormonal therapies. Disease morbidity and mortality remain...